Skip to Content

B419 (Meloxicam 15 mg)

Pill with imprint B419 is Yellow, Elliptical / Oval and has been identified as Meloxicam 15 mg. It is supplied by Breckenridge Pharmaceutical, Inc..

Meloxicam is used in the treatment of osteoarthritis; juvenile rheumatoid arthritis; rheumatoid arthritis; pain and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Meloxicam 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for B419

Meloxicam 15 mg B419

Meloxicam

Imprint
B419
Strength
15 mg
Color
Yellow
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Nonsteroidal anti-inflammatory drugs
Pregnancy Category
C - Risk cannot be ruled out - prior to 30 weeks gestation, D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule
Not a controlled drug
Labeler / Supplier
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC)
51991-0419

Submitted by: fadtron

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.